Masimo Inc. (MASI): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Masimo Personal Health (MASI)

Masimo Corporation has created a deeply integrated non-invasive monitoring environment, making the replacement of its systems in clinics extremely costly. The company's P/S ratio trend visualizes the market valuation of these advantages, where 6.00 captures the current value of the indicator. A monopoly position in the pulse oximetry segment allows the brand to exercise pricing power over consumables, while the implementation of robotic sensor assembly lines optimizes production.

Price-to-Revenue Ratio: Masimo (MASI) for 07/04/2022 - 06/21/2026

Metric breakdowns and analytics for Masimo Personal Health (MASI)

- stock quotes and analyst forecast:
Summary company analytics:masimo.com
Mass-produced product of masimo.com

For Masimo Corporation (MASI), whose critical equipment bypasses trade barriers, the P/S ratio serves as a measure of market value relative to generated revenue. By analyzing the revenue multiple trend, an investor compares market capitalization with actual sales, which allows for the timely identification of speculative overheating and confirms the fundamental stability of the business amid low geopolitical risks.

Competitors of Masimo Corporation

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue stevanatogroup.com|TFX (Teleflex) - P/S Multiple|Price to Sales Merit Medical Systems, Inc. MMSI|Price-to-Revenue Ratio Envista Holdings Corp (NVST)|ICU Medical Inc. - Market Cap to Revenue Ratio|DENTSPLY SIRONA Inc. - Market Cap to Revenue|Market Cap to Sales Volume LMAT (lemaitre.com)|ATRC - Price-to-Revenue Ratio|Price-to-Revenue Coefficient STAAR Surgical Co. STAA|ChromaDex Corp (NAGE) - Price-to-Revenue Ratio|Market Cap to Revenue ZimVie Corp|ANGO (AngioDynamics, Inc.) - P/S Multiple|P/S Multiple cerus.com|Price-to-Revenue Ratio Teknova (TKNO)|Price-to-Revenue Coefficient Monogram Technologies Inc.|P/S Multiple STSS (Sharps Technology)|Price-to-Revenue Coefficient InfuSystem (INFU)|UTMD - Price-to-Revenue Ratio|KORU Medical Systems (KRMD) - Market Cap to Revenue|Nyxoah (NYXH) - Price-to-Revenue Ratio|Price to Sales Microbot Medical, Inc. (MBOT)|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Market Cap to Revenue milestonescientific.com MLSS|Price-to-Revenue Ratio NEXGEL NXGL|Retractable Technologies Inc. (RVP) - Price to Sales|HBIO - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio FEMY (Femasys Corporation)|meihuamed.com (MHUA) - Price-to-Revenue Ratio|Price-to-Sales Ratio POAI (Predictive Oncology Inc.)|Price-to-Revenue Ratio Callan JMB Inc.|Price to Sales Atrion Corp. ATRI|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)